Alk Abello A/S (ALKb.CO) News| Reuters.com
Edition:
United States

Alk Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

1,188.00DKK
9:34am EDT
Change (% chg)

kr.19.00 (+1.63%)
Prev Close
kr.1,169.00
Open
kr.1,172.00
Day's High
kr.1,194.00
Day's Low
kr.1,172.00
Volume
6,144
Avg. Vol
17,848
52-wk High
kr.1,300.00
52-wk Low
kr.689.00

Select another date:

Wed, May 18 2016

BRIEF-ALK-Abello names Carsten Hellmann new CEO

* Said on Tuesday Board of Directors had appointed Carsten Hellmann as new President and Chief Executive

BRIEF-Alk Abello Q1 EBIT rises to DKK 236 million

* Q1 EBIT 236 million Danish crowns ($36.4 million) versus 91 million crowns year ago

BRIEF-Alk Abello: license application for SLIT-tablet accepted for review by FDA

* License application for investigational house dust mite SLIT-tablet accepted for review by fda

BRIEF-Alk Abello CEO Jens Bager steps down

* Search for a new CEO will be initiated immediately Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Alk Abello: MSD submits US license application for investigational house dust mite SLIT-tablet

* ALK's partner, MSD, submits US license application for investigational house dust mite SLIT-tablet

BRIEF-ALK Abello Q4 total revenue up at DKK 687 mln

* Q4 total revenue 687 million Danish crowns ($102.96 million) versus 612 million crowns year ago

BRIEF-Alk Abello expands partnership into South-East Asian growth markets

* Abbott will register and sell house dust mite (HDM) sublingual allergy immunotherapy (SLIT) tablet in 7 new growth markets in SE Asia

BRIEF-ALK Abelló: Marketing authorisation for Acarizax issued in France

* Says that authorities in France have issued a marketing authorisation for ALK's new house dust mite sublingual allergy immuno-therapy tablet (slit-tablet), Acarizax Source text for Eikon:

BRIEF-Alk Abello announces results from GRAZAX Asthma Prevention trial in children

* Announces top-line results from the five-year landmark GRAZAX Asthma Prevention (GAP) trial in children

BRIEF-Alk Abello increases 2015 forecasts after high French sales

* Alk Abello increases 2015 forecasts due to higher sales in France

Select another date: